Skip to main content
. 2023 Aug 4;136(18):2187–2194. doi: 10.1097/CM9.0000000000002797

Table 5.

Safety analysis results of two groups of patients with knee arthritis.

Adverse events

Total

(N = 250)

Flurbiprofen

(N = 125)

Loxoprofen

(N = 125)

P-value
Overall adverse events 49 (19.6) 7 (5.6) 42 (33.6) <0.001
Skin irritation 16 (6.4) 4 (3.2) 12 (9.6) 0.039
Skin rash 15 (6.0) 2 (1.6) 13 (10.4) 0.003
Skin pain 11 (4.4) 2 (1.6) 9 (7.2) 0.031
Sticky hair uncovering pain 36 (14.4) 1 (0.8) 35 (28.0) <0.001
Adverse event severity score* 0 (0–1.0) 0 (0) 0 (0–1.0) <0.001

Data are presented as n (%) and median (interquartile range). *The severity of each adverse event was measured using a scale ranging from 0 to 4, with higher points indicating more severe conditions.